| Serial Number | 97689880 |
| Word Mark | MMTS MULTI MINI TABLET SYSTEM |
| Filing Date | Wednesday, November 23, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, February 11, 2025 |
| Registration Number | 7683627 |
| Registration Date | Tuesday, February 11, 2025 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 11, 2024 |
| Goods and Services | Manufacturing services to the specification of others in the pharmaceutical field and in the veterinary field, in particular in the field of pharmaceutical active substance delivery systems, including customized release, taste masked release, immediate release, pulsatile release, extended release, sustained release, and delayed release systems; clinical manufacturing of drug compositions for others to support clinical trials; manufacturing process consulting services for others relating to technology scale-up and integration of technology into manufacturing processes |
| Certificate of Correction for Registration | In the statement, line 14 - 15, "thrombonemia, ipertriglyceremia, ipercholesterolemia, iperlipoproteinemia" should be deleted, and "thrombocythemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, should be inserted. line 20, "Alzheimer" should be deleted, and "Alzheimer's" should be inserted. |
| Goods and Services | Pharmaceutical and veterinary pharmaceutical preparations, in particular drug delivery compositions, drug carriers and drug delivery agents, capsules, sachets and sprinkles for pharmaceutical purposes, comprising multiparticulates or multiple units, used for the treatment of disorders or diseases in the gastrointestinal tract, in the digestive system, in the gut, in the immune systems, in the cardiovascular system, in the respiratory tract, in the blood, in the metabolism, in the nervous system, in the cognition, in the behavior, and in the reproductive tract, gastrointestinal infections, diarrhea, irritable bowel syndrome, inflammatory bowel syndrome disease, enterocolitis, enteritis, ulcerative colitis, cardiovascular disorders, hypertension, thrombosis, vasoconstriction, asthma, inflammation of respiratory tract, asthma, bronchoconstriction, [ thrombonemia, ipertriglyceremia, ipercholesterolemia, iperlipoproteinemia, ] * thrombocythemia ,hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, * blood anemia, hypocalcemia, diabetes, diabetic peripheral neuropathy, dyskinesia, hyperkinetic movements, enzyme deficiency, pancreatitis, pancreatectomy, steatorrhea, cystic fibrosis, Paget's disease, bacterial infections, viral infections, fungal infections, osteoporosis, cancer, mucosal and systemic inflammation, functional disease, abdominal pain, allergy, obesity, muscle spasticity, spasms, convulsion, dysthymia, schizophrenia, degenerative dementia, [ Alzheimer, ] * Alzheimer's, * stress, anxiety, depression, mood disturbance, sociability disturbance, sleep disturbance, psychological disturbance, attention deficit hyperactivity disorder, addiction, fibromyalgia, obsessive-compulsive disorders, pain, peripheral neuropathic pain, post-surgical pain, back-pain, osteoarthritis |
| NOT AVAILABLE | "MULTI MINI TABLET SYSTEM" |
| Goods and Services | Research and development services in the pharmaceutical field and in the veterinary field, in particular in the field of pharmaceutical active substance delivery systems; research and development services for the preparation of multiparticulates or multiple units dosage forms including capsules, sachets, sprinkles; research and development in the area of delivery systems with customized release, taste masked release, immediate release, pulsatile release, extended release, sustained release, and delayed release; scientific research and development in the area of stability testing, physical characterization, in-vitro release testing |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 15, 2022 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 15, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 15, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ADARE PHARMACEUTICALS s.r.l. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Pessano con Bornago 20042 IT |
| Party Name | ADARE PHARMACEUTICALS s.r.l. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Pessano con Bornago 20042 IT |
| Party Name | ADARE PHARMACEUTICALS s.r.l. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Pessano con Bornago 20042 IT |
| Event Date | Event Description |
| Monday, July 14, 2025 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, December 5, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, May 6, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, January 22, 2025 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Monday, December 9, 2024 | TEAS DELETE 1(B) BASIS RECEIVED |
| Thursday, December 5, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Tuesday, February 18, 2025 | TEAS SECTION 7 REQUEST RECEIVED |
| Tuesday, September 12, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, May 6, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, December 5, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, July 24, 2025 | CORRECTION UNDER SECTION 7 - PROCESSED |
| Saturday, November 26, 2022 | NEW APPLICATION ENTERED |
| Thursday, December 15, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, June 11, 2024 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 22, 2025 | NOTICE OF ALLOWANCE CANCELLED |
| Tuesday, August 6, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, June 11, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, December 5, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, May 2, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 12, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, May 6, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Monday, May 6, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, September 12, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, February 11, 2025 | REGISTERED-PRINCIPAL REGISTER |
| Monday, May 6, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, May 22, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, December 5, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, May 2, 2024 | ASSIGNED TO LIE |
| Thursday, May 2, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 6, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, September 12, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 5, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, February 11, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 12, 2025 | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED |